BIRTAMIMAB
UNII VXQ2SK8I3P

Substance Identification & Data

This profile provides standardized clinical and technical data for Birtamimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VXQ2SK8I3P.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1608108-91-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

VXQ2SK8I3P

CAS Registry Number

1608108-91-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BIRTAMIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C142958

National Cancer Institute reference terminology for clinical and research data.

INN ID

10198

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

BC-154

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Birtamimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BIRTAMIMAB

Common Names & Synonyms

BIRTAMIMAB [INN]

BIRTAMIMAB [USAN]

IMMUNOGLOBULIN G1, ANTI-(HUMAN SERUM AMYLOID A PROTEIN/IMMUNOGLOBULIN AL (AMYLOID LIGHT-CHAIN)) (HUMAN-MUS MUSCULUS MONOCLONAL NEOD001 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL NEOD001 .KAPPA.-CHAIN, DIMER